Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 6—June 2025
Dispatch
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024
Figure

Figure. Live-virus neutralization of preseasonal and postseasonal quadrivalent influenza vaccination in a study of influenza A(H5N1) virus neutralization by quadrivalent seasonal vaccines, United Kingdom, 2021–2024. Violin plots show paired serum samples before and after each seasonal vaccine (top row, 2023–24, n = 59; middle row, 2022–23, n = 54; bottom row, 2021–22, n = 30) tested against pandemic H1 and 2 highly pathogenic avian influenza H5 strains: H1N1 strain (A), H5N1 Cambodia strain (B), and H5H1 Texas dairy strain (C). Virus neutralization reported as log2-transformed IC50. Black diamonds indicate median IC50. Nonspecific cross-reactivity levels are shown as shaded areas. p values from McNemar tests are shown, comparing the number of persons above background (dashed line) before and after quadrivalent influenza vaccination by using a χ2 test. IC50, reciprocal titer at which 50% of viral infection is inhibited; NE, not estimated.
1These authors contributed equally to this article.
2Members of the Crick Neutralization Consortium are listed at the end of this article.
3Members of the Legacy Investigators are listed at the end of this article.